{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:17:18Z","timestamp":1761823038740},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T00:00:00Z","timestamp":1199923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1748-717x-3-2","type":"journal-article","created":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T19:14:00Z","timestamp":1199992440000},"source":"Crossref","is-referenced-by-count":5,"title":["Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?"],"prefix":"10.1186","volume":"3","author":[{"given":"Carsten","family":"Nieder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Pawinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus H","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Molls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,10]]},"reference":[{"key":"95_CR1","first-page":"CD006019","volume-title":"Cochrane Database Syst Rev","author":"S Kumar","year":"2006","unstructured":"Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD: Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev 2006, CD006019."},{"key":"95_CR2","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","volume":"24","author":"NL Keating","year":"2006","unstructured":"Keating NL, O'Malley AJ, Smith MR: Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 2006, 24: 4448-4456. 10.1200\/JCO.2006.06.2497","journal-title":"J Clin Oncol"},{"key":"95_CR3","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1200\/JCO.2006.09.3369","volume":"25","author":"AV D'Amico","year":"2007","unstructured":"D'Amico AV, Denham JW, Crook J, Chen MH, Goldhaber SZ, Lamb DS, Joseph D, Tai KH, Malone S, Ludgate C, Steigler A, Kantoff PW: Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 2007, 25: 2420-2425. 10.1200\/JCO.2006.09.3369","journal-title":"J Clin Oncol"},{"issue":"2 Suppl 1","key":"95_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","volume":"61","author":"CS Higano","year":"2003","unstructured":"Higano CS: Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 2003,61(2 Suppl 1):32-38. 10.1016\/S0090-4295(02)02397-X","journal-title":"Urology"},{"key":"95_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000019546","volume":"33","author":"LJ Denis","year":"1998","unstructured":"Denis LJ, Keuppens F, Smith PH, Whelan P, de Moura JL, Newling D, Bono A, Sylvester R: Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center. Eur Urol 1998, 33: 144-151. 10.1159\/000019546","journal-title":"Eur Urol"},{"key":"95_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2005.06.005","volume":"76","author":"CJ Tyrrell","year":"2005","unstructured":"Tyrrell CJ, Payne H, See WA, McLeod DG, Wirth MP, Iversen P, Armstrong J, Morris C, 'Casodex' Early Prostate Cancer Trialist Group: Bicalutamide ('Casodex') 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: results from the randomised Early Prostate Cancer Programme. Radiother Oncol 2005, 76: 4-10. 10.1016\/j.radonc.2005.06.005","journal-title":"Radiother Oncol"},{"key":"95_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1470-2045(05)70103-0","volume":"6","author":"S Perdona","year":"2005","unstructured":"Perdona S, Autorino R, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Bianco AR, Di Lorenzo G: Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol 2005, 6: 295-300. 10.1016\/S1470-2045(05)70103-0","journal-title":"Lancet Oncol"},{"key":"95_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.eururo.2004.12.003","volume":"47","author":"H Van Poppel","year":"2005","unstructured":"Van Poppel H, Tyrrell CJ, Haustermans K, Cangh PV, Keuppens F, Colombeau P, Morris T, Garside L: Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer. Eur Urol 2005, 47: 587-592. 10.1016\/j.eururo.2004.12.003","journal-title":"Eur Urol"},{"key":"95_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ijrobp.2004.03.022","volume":"60","author":"CJ Tyrrell","year":"2004","unstructured":"Tyrrell CJ, Payne H, Tammela TL, Bakke A, Lodding P, Goedhals L, Van Erps T, Boon T, Van De Beek C, Andersson SO, Morris T, Carroll K: Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int J Radiat Oncol Biol Phys 2004, 60: 476-483. 10.1016\/j.ijrobp.2004.03.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"95_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0090-4295(02)02107-6","volume":"61","author":"A Widmark","year":"2003","unstructured":"Widmark A, Foss\u00e5 SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O: Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7\/SFUO-3. Urology 2003, 61: 145-151. 10.1016\/S0090-4295(02)02107-6","journal-title":"Urology"},{"key":"95_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1442-2042.2005.01145.x","volume":"12","author":"KC Chen","year":"2005","unstructured":"Chen KC, Peng CC, Hsieh HM, Peng CH, Hsieh CL, Huang CN, Chyau CC, Wang HE, Peng RY: Antiandrogenic therapy can cause coronary arterial disease. Int J Urol 2005, 12: 886-891. 10.1111\/j.1442-2042.2005.01145.x","journal-title":"Int J Urol"},{"key":"95_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ijrobp.2004.09.037","volume":"61","author":"J Coleman","year":"2005","unstructured":"Coleman J, Park C, Villarreal-Barajas JE, Petti P, Faddegon B: A comparison of Monte Carlo and Fermi-Eyges-Hogstrom estimates of heart and lung dose from breast electron boost treatment. Int J Radiat Oncol Biol Phys 2005, 61: 621-628. 10.1016\/j.ijrobp.2004.09.037","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"95_CR13","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","volume":"270","author":"SL Hancock","year":"1993","unstructured":"Hancock SL, Tucker MA, Hoppe RT: Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993, 270: 1949-1955. 10.1001\/jama.270.16.1949","journal-title":"JAMA"},{"key":"95_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2307\/3580222","volume":"152","author":"Y Shimizu","year":"1999","unstructured":"Shimizu Y, Pierce DA, Preston DL, Mabuchi K: Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950\u20131990. Radiat Res 1999, 152: 374-389. 10.2307\/3580222","journal-title":"Radiat Res"},{"key":"95_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ijrobp.2004.07.708","volume":"61","author":"ZA Carr","year":"2005","unstructured":"Carr ZA, Land CE, Kleinerman RA, Weinstock RW, Stovall M, Griem ML, Mabuchi K: Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys 2005, 61: 842-850. 10.1016\/j.ijrobp.2004.07.708","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"95_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/bjc.1987.35","volume":"55","author":"SC Darby","year":"1987","unstructured":"Darby SC, Doll R, Gill SK, Smith PG: Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987, 55: 179-190.","journal-title":"Br J Cancer"},{"key":"95_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijrobp.2006.08.071","volume":"67","author":"S Schultz-Hector","year":"2007","unstructured":"Schultz-Hector S, Trott KR: Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 2007, 67: 10-18.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"95_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/djk064","volume":"99","author":"MJ Hooning","year":"2007","unstructured":"Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FJ: Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007, 99: 365-375. 10.1093\/jnci\/djk064","journal-title":"J Natl Cancer Inst"},{"key":"95_CR19","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1200\/JCO.2003.11.023","volume":"21","author":"GE Hanks","year":"2003","unstructured":"Hanks GE, Pajak TF, Porter A, Grignon D, Brereton H, Venkatesan V, Horwitz EM, Lawton C, Rosenthal SA, Sandler HM, Shipley WU, Radiation therapy Oncology Group: Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group protocol 92-02. J Clin Oncol 2003, 21: 3972-3978. 10.1200\/JCO.2003.11.023","journal-title":"J Clin Oncol"},{"key":"95_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1748-717X-2-20","volume":"2","author":"C Nieder","year":"2007","unstructured":"Nieder C, Schill S, Kneschaurek P, Molls M: Influence of different treatment techniques on radiation dose to the LAD coronary artery. Radiat Oncol 2007, 2: 20. 10.1186\/1748-717X-2-20","journal-title":"Radiat Oncol"},{"key":"95_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/jnci\/djj230","volume":"98","author":"VB Shahinian","year":"2006","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS: Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst 2006, 98: 839-845.","journal-title":"J Natl Cancer Inst"},{"key":"95_CR22","first-page":"252","volume-title":"Principles and Practice of Radiation Oncology","author":"KR Hogstrom","year":"2004","unstructured":"Hogstrom KR: Electron-beam therapy: Dosimetry, planning, and techniques. In Principles and Practice of Radiation Oncology. 4th edition. Edited by: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK. Philadelphia (PA): Lippincott, Williams and Wilkins; 2004:252-282.","edition":"4"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-3-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-3-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-3-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:35:03Z","timestamp":1548218103000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-3-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,10]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["95"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-3-2","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,10]]},"article-number":"2"}}